Perez-Favila, A.; Garza-Veloz, I.; Hernandez-Marquez, L.d.S.; Gutierrez-Vela, E.F.; Flores-Morales, V.; Martinez-Fierro, M.L.
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers. Int. J. Mol. Sci. 2024, 25, 1562.
https://doi.org/10.3390/ijms25031562
AMA Style
Perez-Favila A, Garza-Veloz I, Hernandez-Marquez LdS, Gutierrez-Vela EF, Flores-Morales V, Martinez-Fierro ML.
Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers. International Journal of Molecular Sciences. 2024; 25(3):1562.
https://doi.org/10.3390/ijms25031562
Chicago/Turabian Style
Perez-Favila, Aurelio, Idalia Garza-Veloz, Lucia del Socorro Hernandez-Marquez, Edgar Fernando Gutierrez-Vela, Virginia Flores-Morales, and Margarita L. Martinez-Fierro.
2024. "Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers" International Journal of Molecular Sciences 25, no. 3: 1562.
https://doi.org/10.3390/ijms25031562
APA Style
Perez-Favila, A., Garza-Veloz, I., Hernandez-Marquez, L. d. S., Gutierrez-Vela, E. F., Flores-Morales, V., & Martinez-Fierro, M. L.
(2024). Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers. International Journal of Molecular Sciences, 25(3), 1562.
https://doi.org/10.3390/ijms25031562
